TY - JOUR
T1 - Biofabrication of multiscale bone extracellular matrix scaffolds for bone tissue engineering
AU - Freeman, F. E.
AU - Browe, D. C.
AU - Diaz-Payno, P. J.
AU - Nulty, J.
AU - Von Euw, S.
AU - Grayson, W. L.
AU - Kelly, Daniel J.
N1 - Funding Information:
This publication was supported by a research grant from the European Research Council (ERC) under the grant number 647004 and the Irish Research Council (GOIPD/2016/324). SVE was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 793861. Authors declare that no competing financial interests exist.
Funding Information:
of spatially complex musculoskeletal tissues. This publication was supported by a research grant Biomaterials 188: 63-73. from the European Research Council (ERC) under d’Aquino R, De Rosa A, Lanza V, Tirino V, Laino L, the grant number 647004 and the Irish Research Graziano A, Desiderio V, Laino G, Papaccio G (2009) Council (GOIPD/2016/324). SVE was supported by Human mandible bone defect repair by the grafting the European Union’s Horizon 2020 research and of dental pulp stem/progenitor cells and collagen innovation program under the Marie Sklodowska-sponge biocomplexes. Eur Cell Mater 18: 75-83. Curie grant agreement No 793861. Daly AC, Cunniffe GM, Sathy BN, Jeon O, Alsberg Authors declare that no competing financial E, Kelly DJ (2016) 3D bioprinting of developmentally interests exist. inspired templates for whole bone organ engineering. Adv Healthc Mater 5: 2353-2362.
Publisher Copyright:
© 2019, AO Research Institute Davos. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Interconnected porosity is critical to the design of regenerative scaffolds, as it permits cell migration, vascularisation and diffusion of nutrients and regulatory molecules inside the scaffold. 3D printing is a promising strategy to achieve this as it allows the control over scaffold pore size, porosity and interconnectivity. Thus, the aim of the present study was to integrate distinct biofabrication strategies to develop a multiscale porous scaffold that was not only mechanically functional at the time of implantation, but also facilitated rapid vascularisation and provided stem cells with appropriate cues to enable their differentiation into osteoblasts. To achieve this, polycaprolactone (PCL) was functionalised with decellularised bone extracellular matrix (ECM), to produce osteoinductive filaments for 3D printing. The addition of bone ECM to the PCL not only increased the mechanical properties of the resulting scaffold, but also increased cellular attachment and enhanced osteogenesis of mesenchymal stem cells (MSCs). In vivo, scaffold pore size determined the level of vascularisation, with a larger filament spacing supporting faster vessel in-growth and more new bone formation. By freeze-drying solubilised bone ECM within these 3D-printed scaffolds, it was possible to introduce a matrix network with microscale porosity that further enhanced cellular attachment in vitro and increased vessel infiltration and overall levels of new bone formation in vivo. To conclude, an “off-the-shelf” multiscale bone-ECM-derived scaffold was developed that was mechanically stable and, once implanted in vivo, will drive vascularisation and, ultimately, lead to bone regeneration.
AB - Interconnected porosity is critical to the design of regenerative scaffolds, as it permits cell migration, vascularisation and diffusion of nutrients and regulatory molecules inside the scaffold. 3D printing is a promising strategy to achieve this as it allows the control over scaffold pore size, porosity and interconnectivity. Thus, the aim of the present study was to integrate distinct biofabrication strategies to develop a multiscale porous scaffold that was not only mechanically functional at the time of implantation, but also facilitated rapid vascularisation and provided stem cells with appropriate cues to enable their differentiation into osteoblasts. To achieve this, polycaprolactone (PCL) was functionalised with decellularised bone extracellular matrix (ECM), to produce osteoinductive filaments for 3D printing. The addition of bone ECM to the PCL not only increased the mechanical properties of the resulting scaffold, but also increased cellular attachment and enhanced osteogenesis of mesenchymal stem cells (MSCs). In vivo, scaffold pore size determined the level of vascularisation, with a larger filament spacing supporting faster vessel in-growth and more new bone formation. By freeze-drying solubilised bone ECM within these 3D-printed scaffolds, it was possible to introduce a matrix network with microscale porosity that further enhanced cellular attachment in vitro and increased vessel infiltration and overall levels of new bone formation in vivo. To conclude, an “off-the-shelf” multiscale bone-ECM-derived scaffold was developed that was mechanically stable and, once implanted in vivo, will drive vascularisation and, ultimately, lead to bone regeneration.
KW - 3D printing
KW - Bone
KW - Extracellular matrix
KW - Mesenchymal stem cells
KW - Osteogenesis
KW - Tissue engineering
UR - http://www.scopus.com/inward/record.url?scp=85073107135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073107135&partnerID=8YFLogxK
U2 - 10.22203/eCM.v038a12
DO - 10.22203/eCM.v038a12
M3 - Article
C2 - 31602629
AN - SCOPUS:85073107135
SN - 1473-2262
VL - 38
SP - 168
EP - 187
JO - European Cells and Materials
JF - European Cells and Materials
ER -